Home › Funds › Bain Capital Life Sciences Investors, LLC › SVRA

Bain Capital Life Sciences Investors, LLC position in SVRA

SAVARA INC · Health Care

Bain Capital Life Sciences Investors, LLC reported holding 17,600,621 shares of SVRA (SAVARA INC) in its Q3 2026 13F filing — a position valued at US$90.8M, representing 6.25% of its reported portfolio and ranking #6 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed SVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)17.60M sh
Reported value held$90.82M
Portfolio Weight6.25%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Bain Capital Life Sciences Investors, LLC's SVRA position evolved

Bain Capital Life Sciences Investors, LLC first disclosed a stake in SVRA in Q3 2023 at 14,232,751 shares (US$53.8M). The position peaked in Q2 2026 at 17,600,621 shares, worth US$108.4M. Across 13 filings, Bain Capital Life Sciences Investors, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 17,600,621 shares valued at US$90.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.23M $53.80M New
Q4 2023 14.23M $66.89M Hold
Q1 2024 14.57M $72.54M Add
Q2 2024 14.57M $58.70M Hold
Q3 2024 14.57M $61.76M Hold
Q4 2024 14.57M $44.72M Hold
Q1 2025 17.60M $48.75M Add
Q2 2025 17.60M $40.13M Hold
Q3 2025 17.60M $62.83M Hold
Q4 2025 17.60M $106.13M Hold
Q1 2026 17.60M $96.10M Hold
Q2 2026 17.60M $108.42M Hold
Q3 2026 17.60M $90.82M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SVRA and 13F data

SVRA (SAVARA INC) is a Health Care company. 38 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Venrock Adviser, LLC (US$90.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$83.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SVRA

All SVRA fund holders →

FAQ

How long has Bain Capital Life Sciences Investors, LLC held SVRA?

Bain Capital Life Sciences Investors, LLC has disclosed SVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Bain Capital Life Sciences Investors, LLC's current position in SVRA?

As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 17.60M shares of SVRA (SAVARA INC), valued at $90.82M, representing 6.25% of its reported portfolio and ranking #6.

Has Bain Capital Life Sciences Investors, LLC been buying or selling SVRA?

In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in SVRA. The position peaked in Q2 2026 at 17.60M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Venrock Adviser, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.